Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial

• Main Authors: Sotomi Y., Ishibashi Y., Suwannasom P., Nakatani S., Cho Y., Grundeken M., Zeng Y., Tateishi H., Smits P., Barragan P., Kornowski R., Gershlick A., Windecker S., van Geuns R., Bartorelli A., de Winter R., Tijssen J., Serruys P., Onuma Y.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84994044884&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/41791
• Institution: Chiang Mai University

© 2016 American College of Cardiology Foundation Objectives The study compared, by intravascular ultrasound (IVUS), acute gain (AG) at the site of the pre-procedural minimal lumen area (MLA) achieved by either the Absorb (Abbott Vascular, Santa Clara, California) scaffold or the Xience stent and ide...